| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 698459 | Null | 0.048939380959983 | -0.04847866 |
| NSC 724907 | 8-Chloro-7-cyano-3-(1-naphthylamino)-5,5-dioxo[1,2,4]triazol o[4,3-b][1,4,2]benzodithiazine | 0.048939380959983 | 0.24326902 |
| NSC 730035 | 6-amino-5-(4-fluorobenzyl)-7-(1-methyl-1H-benzo[d]imidazol-2 -yl)-5H-pyrrolo[2,3-b]pyrazine-2,3-dicarbonitrile | 0.048939380959983 | 0.12798957 |
| NSC 108165 | CP 12252-1 | 0.0489393809599834 | 0.56602765 |
| NSC 144173 | Quinoxaline, 2,3-bis(iodomethyl)-6-methoxy- | 0.0489393809599834 | 0.67730588 |
| NSC 200692 | Aspiculamycin hydrochloride | 0.0489393809599834 | -0.31880963 |
| NSC 2604 | D.b.t.c. | 0.0489393809599834 | 0.52818368 |
| NSC 268965 | Benzaldehyde, 4-[bis[2-[(methylsulfonyl)oxy]ethyl]amino]- | 0.0489393809599834 | -0.13666424 |
| NSC 368697 | Benz[a]anthracene-1,7,12(12b-H)-trione, 2,3,4,4a-tetra- hydro-2,3,4a,8,12a-pentahydroxy-3-methyl- | 0.0489393809599834 | 0.63177353 |
| NSC 625498 | 4-Morpholinecarbodithioic acid, antimony complex | 0.0489393809599834 | 0.3700204 |